Clinical Trials Browser

INDUSTRY × Interventional × racemetyrosine × Clear all

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Phase 2/3 Terminated

130 enrolled 13 charts

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT02562612 2022-07-01

Study of SM-88 in Advanced Cancers

Phase 1/2 Withdrawn

Breast Neoplasms

NCT02796898 2019-07-22

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms